1 CURRICULUM VITAE – DANIEL ABRAMOWICZ ... - Oxford Journals
1 CURRICULUM VITAE – DANIEL ABRAMOWICZ ... - Oxford Journals
1 CURRICULUM VITAE – DANIEL ABRAMOWICZ ... - Oxford Journals
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
GOLDMAN M<br />
Injection of anti-CD3 mitogenic monoclonal antibodies in mice selectively inhibits the<br />
function of TH1-like cells in vivo.<br />
Second meeting of the Belgian Transplantation Society, Anvers, March 1995.<br />
47. DONCKIER V, WISSING M, <strong>ABRAMOWICZ</strong> D, BRUYNS C, LYBIN M,<br />
VANDERHAEGEN ML, GOLDMAN M<br />
Role of Interleukin-4 in neonatal induction of transplantation tolerance in mice.<br />
Second meeting of the Belgian Transplantation Society, Anvers, March 1995.<br />
48. <strong>ABRAMOWICZ</strong> D, DE PAUW L, LE MOINE A, SERMON F, SURQUIN M,<br />
DOUTRELEPONT JM, ICKX B, DEPIERREUX M, VANHERWEGHEM JL,<br />
KINNAERT P, GOLDMAN M, VEREERSTRAETEN P<br />
Prevention of OKT3 nephrotoxicity after kidney transplantation.<br />
BVN-SBN meeting, Mons, 20-5-1995<br />
49. LE MOINE A, <strong>ABRAMOWICZ</strong> D, DE PAUW L, DEPIERREUX M,<br />
DOUTRELEPONT JM, VANHERWEGHEM JL, KINNAERT P,<br />
VEREERSTRAETEN P<br />
Long-term kidney graft survival after CSA discontinuation for nephrotoxicity.<br />
BVN-SBN meeting, Mons, 20-5-1995<br />
50. DOUTRELEPONT JM, DE PAUW L, KINNAERT P, VEREERSTRAETEN P, PENN<br />
I, <strong>ABRAMOWICZ</strong> D<br />
Should we retransplant patients who developed Kaposi's sarcoma during a first<br />
transplantation ?<br />
BVN-SBN meeting, Mons, 20-5-1995<br />
51. VEREERSTRAETEN P, DUPONT E, ANDRIEN M, <strong>ABRAMOWICZ</strong> D, DE PAUW<br />
L, DOUTRELEPONT JM, KINNAERT P.<br />
Permissible HLA-DR mismatches increase the pool of potential kidney transplant<br />
recipients without jeopardizing long term graft survival.<br />
Eurotransplant Meeting, Leiden, The Netherlands, September 21-22, 1995<br />
52. WISSING M, ALEGRE M, <strong>ABRAMOWICZ</strong> D, WILLEMS F, GOLDMAN M<br />
L'immunosuppression induite par les anticorps anti-CD3 dépend de leur pouvoir<br />
activateur<br />
Société de Néphrologie, Caen, Octobre 1995<br />
53. DOUTRELEPONT JM, DE PAUW L, KINNAERT P, VEREERSTRAETEN P,<br />
PENN I, <strong>ABRAMOWICZ</strong> D<br />
66